<?xml version="1.0" encoding="UTF-8"?>
<!-- Generated on Sat, 22 Aug 2026 18:18:48 -0400 -->
<rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>    <title>Cocrystal Pharma, Inc. (COCP) News</title>
    <link>https://ir.cocrystalpharma.com/all-sec-filings/rss</link>
    <description>Cocrystal Pharma, Inc. (COCP) - All SEC Filings</description>
    <language>en-us</language>
    <generator>Equisolve Investor Relations Suite</generator>
    <image>
      <url>http://content.stockpr.com/cocrystalpharma/files/logo.png</url>
      <title></title>
      <link>https://www.cocrystalpharma.com</link>
      <width></width>
      <height></height>
    </image>
    <item>
      <title><![CDATA[ 3 - Initial statement of beneficial ownership of securities ]]></title>
      <description><![CDATA[ 2 Related Documents:<br />3, EX-24 ]]></description>
      <link>https://ir.cocrystalpharma.com/all-sec-filings?page=1#document-3923-0001493152-26-039674</link>
      <pubDate>Fri, 21 Aug 26 16:11:19 -0400</pubDate>
      <guid isPermaLink="true">https://ir.cocrystalpharma.com/all-sec-filings?page=1#document-3923-0001493152-26-039674</guid>
    </item>
    <item>
      <title><![CDATA[ 8-K - Current report ]]></title>
      <description><![CDATA[ 8-K ]]></description>
      <link>https://ir.cocrystalpharma.com/all-sec-filings?page=1#document-3921-0001493152-26-039023</link>
      <pubDate>Tue, 18 Aug 26 16:31:03 -0400</pubDate>
      <guid isPermaLink="true">https://ir.cocrystalpharma.com/all-sec-filings?page=1#document-3921-0001493152-26-039023</guid>
    </item>
    <item>
      <title><![CDATA[ 8-K - Current report ]]></title>
      <description><![CDATA[ 2 Related Documents:<br />8-K, EX-99.1 ]]></description>
      <link>https://ir.cocrystalpharma.com/all-sec-filings?page=1#document-3920-0001493152-26-038747</link>
      <pubDate>Mon, 17 Aug 26 16:17:03 -0400</pubDate>
      <guid isPermaLink="true">https://ir.cocrystalpharma.com/all-sec-filings?page=1#document-3920-0001493152-26-038747</guid>
    </item>
    <item>
      <title><![CDATA[ 10-Q - Quarterly report [Sections 13 or 15(d)] ]]></title>
      <description><![CDATA[ 4 Related Documents:<br />10-Q, EX-31.1, EX-31.2, EX-32.1 ]]></description>
      <link>https://ir.cocrystalpharma.com/all-sec-filings?page=1#document-3918-0001493152-26-037573</link>
      <pubDate>Thu, 13 Aug 26 07:30:25 -0400</pubDate>
      <guid isPermaLink="true">https://ir.cocrystalpharma.com/all-sec-filings?page=1#document-3918-0001493152-26-037573</guid>
    </item>
    <item>
      <title><![CDATA[ SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership ]]></title>
      <description><![CDATA[ 4 Related Documents:<br />SCHEDULE 13D, EX-1, EX-2, EX-4 ]]></description>
      <link>https://ir.cocrystalpharma.com/all-sec-filings?page=1#document-3914-0000944809-26-000002</link>
      <pubDate>Fri, 07 Aug 26 19:50:34 -0400</pubDate>
      <guid isPermaLink="true">https://ir.cocrystalpharma.com/all-sec-filings?page=1#document-3914-0000944809-26-000002</guid>
    </item>
    <item>
      <title><![CDATA[ SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership ]]></title>
      <description><![CDATA[ SCHEDULE 13D/A ]]></description>
      <link>https://ir.cocrystalpharma.com/all-sec-filings?page=1#document-3910-0001493152-26-036650</link>
      <pubDate>Fri, 07 Aug 26 17:13:13 -0400</pubDate>
      <guid isPermaLink="true">https://ir.cocrystalpharma.com/all-sec-filings?page=1#document-3910-0001493152-26-036650</guid>
    </item>
    <item>
      <title><![CDATA[ 4 - Statement of changes in beneficial ownership of securities ]]></title>
      <description><![CDATA[ 4 ]]></description>
      <link>https://ir.cocrystalpharma.com/all-sec-filings?page=1#document-3909-0001493152-26-036396</link>
      <pubDate>Thu, 06 Aug 26 17:37:15 -0400</pubDate>
      <guid isPermaLink="true">https://ir.cocrystalpharma.com/all-sec-filings?page=1#document-3909-0001493152-26-036396</guid>
    </item>
    <item>
      <title><![CDATA[ 4 - Statement of changes in beneficial ownership of securities ]]></title>
      <description><![CDATA[ 4 ]]></description>
      <link>https://ir.cocrystalpharma.com/all-sec-filings?page=1#document-3908-0001493152-26-036169</link>
      <pubDate>Wed, 05 Aug 26 16:23:56 -0400</pubDate>
      <guid isPermaLink="true">https://ir.cocrystalpharma.com/all-sec-filings?page=1#document-3908-0001493152-26-036169</guid>
    </item>
    <item>
      <title><![CDATA[ 8-K - Current report ]]></title>
      <description><![CDATA[ 3 Related Documents:<br />8-K, EX-10.1, EX-99.1 ]]></description>
      <link>https://ir.cocrystalpharma.com/all-sec-filings?page=1#document-3907-0001493152-26-035743</link>
      <pubDate>Mon, 03 Aug 26 07:15:56 -0400</pubDate>
      <guid isPermaLink="true">https://ir.cocrystalpharma.com/all-sec-filings?page=1#document-3907-0001493152-26-035743</guid>
    </item>
    <item>
      <title><![CDATA[ 8-K - Current report ]]></title>
      <description><![CDATA[ 8-K ]]></description>
      <link>https://ir.cocrystalpharma.com/all-sec-filings?page=1#document-3904-0001493152-26-033662</link>
      <pubDate>Fri, 17 Jul 26 08:00:44 -0400</pubDate>
      <guid isPermaLink="true">https://ir.cocrystalpharma.com/all-sec-filings?page=1#document-3904-0001493152-26-033662</guid>
    </item>
    <item>
      <title><![CDATA[ 8-K - Current report ]]></title>
      <description><![CDATA[ 2 Related Documents:<br />8-K, EX-10.1 ]]></description>
      <link>https://ir.cocrystalpharma.com/all-sec-filings?page=2#document-3903-0001493152-26-027837</link>
      <pubDate>Tue, 09 Jun 26 07:00:55 -0400</pubDate>
      <guid isPermaLink="true">https://ir.cocrystalpharma.com/all-sec-filings?page=2#document-3903-0001493152-26-027837</guid>
    </item>
    <item>
      <title><![CDATA[ 3 - Initial statement of beneficial ownership of securities ]]></title>
      <description><![CDATA[ 2 Related Documents:<br />3, EX-24 ]]></description>
      <link>https://ir.cocrystalpharma.com/all-sec-filings?page=2#document-3901-0001493152-26-027053</link>
      <pubDate>Wed, 03 Jun 26 16:11:25 -0400</pubDate>
      <guid isPermaLink="true">https://ir.cocrystalpharma.com/all-sec-filings?page=2#document-3901-0001493152-26-027053</guid>
    </item>
    <item>
      <title><![CDATA[ 4 - Statement of changes in beneficial ownership of securities ]]></title>
      <description><![CDATA[ 4 ]]></description>
      <link>https://ir.cocrystalpharma.com/all-sec-filings?page=2#document-3899-0001493152-26-027054</link>
      <pubDate>Wed, 03 Jun 26 16:11:12 -0400</pubDate>
      <guid isPermaLink="true">https://ir.cocrystalpharma.com/all-sec-filings?page=2#document-3899-0001493152-26-027054</guid>
    </item>
    <item>
      <title><![CDATA[ 8-K - Current report ]]></title>
      <description><![CDATA[ 2 Related Documents:<br />8-K, EX-99.1 ]]></description>
      <link>https://ir.cocrystalpharma.com/all-sec-filings?page=2#document-3898-0001493152-26-026965</link>
      <pubDate>Wed, 03 Jun 26 07:00:39 -0400</pubDate>
      <guid isPermaLink="true">https://ir.cocrystalpharma.com/all-sec-filings?page=2#document-3898-0001493152-26-026965</guid>
    </item>
    <item>
      <title><![CDATA[ DEF 14A - Definitive proxy statements ]]></title>
      <description><![CDATA[ DEF 14A ]]></description>
      <link>https://ir.cocrystalpharma.com/all-sec-filings?page=2#document-3892-0001493152-26-025428</link>
      <pubDate>Wed, 27 May 26 16:33:01 -0400</pubDate>
      <guid isPermaLink="true">https://ir.cocrystalpharma.com/all-sec-filings?page=2#document-3892-0001493152-26-025428</guid>
    </item>
    <item>
      <title><![CDATA[ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material ]]></title>
      <description><![CDATA[ DEFA14A ]]></description>
      <link>https://ir.cocrystalpharma.com/all-sec-filings?page=2#document-3893-0001493152-26-025430</link>
      <pubDate>Wed, 27 May 26 16:33:19 -0400</pubDate>
      <guid isPermaLink="true">https://ir.cocrystalpharma.com/all-sec-filings?page=2#document-3893-0001493152-26-025430</guid>
    </item>
    <item>
      <title><![CDATA[ 8-K - Current report ]]></title>
      <description><![CDATA[ 2 Related Documents:<br />8-K, EX-99.1 ]]></description>
      <link>https://ir.cocrystalpharma.com/all-sec-filings?page=2#document-3891-0001493152-26-025172</link>
      <pubDate>Tue, 26 May 26 08:30:50 -0400</pubDate>
      <guid isPermaLink="true">https://ir.cocrystalpharma.com/all-sec-filings?page=2#document-3891-0001493152-26-025172</guid>
    </item>
    <item>
      <title><![CDATA[ 10-Q - Quarterly report [Sections 13 or 15(d)] ]]></title>
      <description><![CDATA[ 5 Related Documents:<br />10-Q, EX-31.1, EX-31.2, EX-31.3, EX-32.1 ]]></description>
      <link>https://ir.cocrystalpharma.com/all-sec-filings?page=2#document-3889-0001493152-26-023377</link>
      <pubDate>Fri, 15 May 26 08:31:21 -0400</pubDate>
      <guid isPermaLink="true">https://ir.cocrystalpharma.com/all-sec-filings?page=2#document-3889-0001493152-26-023377</guid>
    </item>
    <item>
      <title><![CDATA[ EFFECT - Notice of Effectiveness ]]></title>
      <description><![CDATA[ EFFECT ]]></description>
      <link>https://ir.cocrystalpharma.com/all-sec-filings?page=2#document-3884-9999999995-26-001445</link>
      <pubDate>Mon, 04 May 26 06:05:23 -0400</pubDate>
      <guid isPermaLink="true">https://ir.cocrystalpharma.com/all-sec-filings?page=2#document-3884-9999999995-26-001445</guid>
    </item>
    <item>
      <title><![CDATA[ 8-K - Current report ]]></title>
      <description><![CDATA[ 2 Related Documents:<br />8-K, EX-99.1 ]]></description>
      <link>https://ir.cocrystalpharma.com/all-sec-filings?page=2#document-3883-0001493152-26-020586</link>
      <pubDate>Thu, 30 Apr 26 16:34:52 -0400</pubDate>
      <guid isPermaLink="true">https://ir.cocrystalpharma.com/all-sec-filings?page=2#document-3883-0001493152-26-020586</guid>
    </item>
  </channel></rss>